“High cost of the gender selection procedure and rising demand for identifying and selecting the gender by mothers increases the market share of PGD in gender selection. Restrictions on gender selection and detection of X-linked diseases in developing regions such as Asia Pacific, Latin America and Africa restrain the growth of the PGD market.”

SB Wire, June 19, 2018.

URL: www.sbwire.com/press-releases/preimplantation-genetic/release-997199.htm?utm_source=djournal&utm_medium=feed&utm_campaign=distribution